Researchers at the Stanford University School of Medicine have found that formoterol ̶ an FDA-approved drug for treating asthma and similar respiratory disorders ̶ improves cognitive function in mice genetically altered to exhibit symptoms of Down syndrome including cognitive disability. Formoterol was chosen for the study because it activates β2 adrenergic receptors (β2ARs) on neurons, a task also carried out by norepinephrine, a neurotransmitter with a...
Read More